Cell Signaling Technology

Cyclosporin A

#9973 · $116

100
Citing papers
3.7k
Combined citations
Supplier page Find this product

Research areas

Axon Guidance and Neuronal Signaling13Chronic Lymphocytic Leukemia Research10Alzheimer's disease research and treatments9Neurogenesis and neuroplasticity mechanisms8Mast cells and histamine7Chronic Myeloid Leukemia Treatments7Nerve injury and regeneration7Neuroinflammation and Neurodegeneration Mechanisms7

Papers citing this product

1
Leukocyte Common Antigen-Related Phosphatase Is a Functional Receptor for Chondroitin Sulfate Proteoglycan Axon Growth Inhibitors
Journal of Neuroscience·2011·307 cit.·DOI
2
CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
Brain·2019·239 cit.·DOI
3
Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
PLoS ONE·2013·225 cit.·DOI
4
Amyloid-β1–42 oligomer accelerates senescence in adult hippocampal neural stem/progenitor cells via formylpeptide receptor 2
Cell Death and Disease·2013·149 cit.·DOI
5
An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Cell Research·2021·135 cit.·DOI
6
Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms
Journal of Clinical Investigation·2019·125 cit.·DOI
7
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation
Brain·2012·117 cit.·DOI
8
BCR signaling inhibitors differ in their ability to overcome Mcl-1–mediated resistance of CLL B cells to ABT-199
Blood·2016·113 cit.·DOI
9
Arabidopsis Actin-Depolymerizing Factor-4 Links Pathogen Perception, Defense Activation and Transcription to Cytoskeletal Dynamics
PLoS Pathogens·2012·108 cit.·DOI
10
Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy
Journal of Neuroscience·2016·97 cit.·DOI